Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 4/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | DNM2 | P50570 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17384346 | 0.89 | ALDH1A1 (0.61) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL17384135 | 0.83 | ALDH1A1 (0.68) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL16644575 | 0.82 | ALDH1A1 (0.67) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL17373036 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL17373035 | 0.81 | ALDH1A1 (0.45) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL17384242 | 0.80 | ALDH1A1 (0.67) | ALDH1A1CA4CA12PTGESMET | |
| SCHEMBL19004802 | 0.75 | ALDH1A1 (0.61) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL18998860 | 0.74 | ALDH1A1 (0.65) | ALDH1A1CA4CA12CA7PTGES | |
| SCHEMBL29967778 | 0.73 | MET (0.47) | ALDH1A1CA4CA12PTGESMET | |
| SCHEMBL11849348 | 0.73 | CTDSP1 (0.58) | ALDH1A1CA12POLBPPARACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10450411-B2 | Copolyesterimides comprising bis(2-hydroxyalkyl)-2,2′-(1,4-phenylene)bis(1,3-dioxoisoindoline-5-carboxylate) and articles made therefrom | DUPONT TEIJIN FILMS U.S. LIMITED PARTNERSHIP (US) | 2019-10-22 | — | — | US | disclosed |
| EP-3157977-B1 | COPOLYESTERIMIDES COMPRISING BIS(2-HYDROXYALKYL)-2,2'-(1,4-PHENYLENE)BIS(1,3-DIOXOISOINDOLINE-5-CARBOXYLATE) AND ARTICLES MADE THEREFROM | DUPONT TEIJIN FILMS US LP (US) | 2018-07-18 | — | — | EP | disclosed |
| US-20170174831-A1 | COPOLYESTERIMIDES COMPRISING BIS(2-HYDROXYALKYL)-2,2'-(1,4-PHENYLENE)BIS(1,3-DIOXOISOINDOLINE-5-CARBOXYLATE) AND ARTICLES MADE THEREFROM | DUPONT TEIJIN FILMS U.S. LIMITED PARTNERSHIP (US) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450411-B2 | Copolyesterimides comprising bis(2-hydroxyalkyl)-2,2′-(1,4-phenylene)bis(1,3-dioxoisoindoline-5-carboxylate) and articles made therefrom | NOTUM, WEE1, WEE2 | ALDH1A1 723/4885CA4 1249/4885CA12 2068/4885 |
| US-20170174831-A1 | COPOLYESTERIMIDES COMPRISING BIS(2-HYDROXYALKYL)-2,2'-(1,4-PHENYLENE)BIS(1,3-DIOXOISOINDOLINE-5-CARBOXYLATE) AND ARTICLES MADE THEREFROM | PUF60, PDS5A, DDT | ALDH1A1 135/4885CA4 791/4885CA12 1511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.